Researchers at the Wyss Institute have described an organ-on-a-chip microfluidic model of pulmonary edema that could be better than culture models at predicting whether therapeutics will translate to humans. The team already has used the model in proof-of-concept studies to test potential pulmonary edema therapeutic candidates and wants to expand the use of the chip to model multiple lung diseases.